Treating Fairly
The ASH Treating Fairly Research Award program was established in response to concerns about recent shifts in federal funding priorities, which have reduced support for research focused on hematologic diseases and disorders that disproportionately affect specific communities. ASH has long recognized the importance of addressing these disparities and remains committed to advancing equitable and fair outcomes for all patients. Securing funding for research that supports this mission is essential.
Key Information
Eligibility Requirements
Applicants must be ASH members serving as Principal Investigators at eligible institutions, be U.S., Mexico, or Canadian citizens (or visa/PR holders conducting research in the U.S., Mexico, or Canada), have no more than $500,000 in other resources, and meet all criteria by the application deadline. See Additional Eligibility RequirementsApplication Process and Required Materials
Applications must be submitted through the ASH online awards system and include all required forms, statements, budget details, biographical sketch, project proposal, ethical certification, and resource information. See Additional Information on Required MaterialsEvaluation and Selection
Award applications are assessed based on the scientific merit and qualifications of the applicant. To maintain programmatic balance, a maximum of two awards will be granted per medical school. Individuals selected to receive this award will be notified in March 2026 with the award commencing upon notification. See Evaluation CriteriaKey Dates
| Application Available | September 15, 2025 |
| Application Deadline | December 31, 2025 |
| Award Notification | March 2026 |
| Award Activation | Upon Notification |
Have a Question?
For general questions about the application, visit the Bridge Grant Frequently Asked Questions (FAQ) page or contact [email protected].